Beijing Poly-Pharma

Beijing Poly Biopharm is an innovative biotechnology company and R&D institute jointly established by the Institute of High Energy Physics (IHEP) of the Chinese Academy of Sciences and Hainan Poly Pharm (Puli Pharma). The company specializes in the transformation of advanced technologies in drug delivery systems, nanobiotechnology, and nucleic acid and protein therapeutics. Its core focus is the development of Boron Neutron Capture Therapy (BNCT) and novel targeted boron carriers for precision oncology. Beijing Poly Biopharm leverages its partnership with IHEP to advance combination therapies for various tumors and explores applications in microbiology and small molecule compounds. The company's pipeline includes multiple boron carrier candidates and bimodal contrast agents currently in the pre-clinical research stage.